NATtrol SARS-CoV-2 External Run Controls are formulated with purified, intact viral particles (Positive control) and human A549 cells (Negative control)….Read More
Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study
Background: Fibroblast growth factor (FGF-23) concentration, a hormone that governs the phosphorus and the metabolism of vitamin D, increase as…Read More
Investigating the causal effect of fibroblast growth factor 23 on osteoporosis and cardiometabolic disorders: A Mendelian randomization study
The pathological excess of fibroblast growth factor 23 (FGF23) causes mineral disorders and bones. However, the causality of the FGF23…Read More
Effect of HBO therapy on adipose-derived stem cells, fibroblasts and co-cultures: In vitro study of oxidative stress, angiogenic potential and production of pro-inflammatory growth factors in co-cultures1
Background: A key moderator of wound healing is oxygen. The healing of the wounds is a dynamic and carefully orchestrated…Read More
Safety and efficacy of basic fibroblast growth factors for deep second-degree burn patients
Introduction: Burning wounds are common afflictions; However, conservative wound care frequently lead to poor compliance with physical treatment and disability…Read More
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
S1400D is a biomarker-driven therapeutic substudy Lung-MAP evaluate fibroblast growth factor (FGF) receptor (FGFR) inhibitor AZD4547 in patients with squamous…Read More
Fibroblast growth factor-2 and interleukin-4 synergistically induce eotaxin-1 expression in adipose tissue-derived stromal cells.
The relationship between eosinophils and adipose tissues involved in metabolic homeostasis. Eotaxin is a chemokine with potent effects on eosinophil…Read More